Enzymotec is pleased to announce that it was awarded among the top 12 companies chosen at the Deloitte Israel Technology Fast 50.
The Deloitte Technology Fast 50 program is part of the Global Fast 500 program .
The Fast 50 winners list consist of Israeli technology companies that match the program criteria which based on five-year revenue growth in percentage between 2003 and 2007 based on audited figures.
Enzymotec is proud with its 5 year growth of 2,134%.
Enzymotec is a developer and manufacturer of innovative, lipid-based biofunctional ingredients for dietary supplements, clinical nutrition and advanced infant nutrition. Key products are: SharpPS® line of products- phosphatidylserine based ingredients for cognitive improvement, InFat® - structured fat for infant formulas, Krill Oil+™ , CardiaBeat® and recently launched Crill™.
Mr. Oren Bryan, Enzymotec CFO " we are sure that the new line of product we are currently launching in combination with reinforcing our current line of products by further research and clinical trials will allow us to maintain our position in the top Technology Fast 50".